need
look
size
growth
intern
nucleotid
databas
realiz
import
sequenc
scienc
gener
virolog
particular
latest
publish
releas
genbank
august
million
million
base
viral
phage
origin
respect
repres
annual
growth
fig
benson
et
al
growth
rate
comfort
averag
databas
whole
sequenc
effort
driven
almost
entir
human
clinic
signific
top
sequenc
virus
caus
diseas
human
fig
entireti
sequenc
effort
repres
signific
achiev
inform
gener
widerang
impact
area
virolog
diagnosi
pathogenesi
vaccin
design
viral
evolut
ecolog
output
possibl
embrac
outset
two
groundbreak
revolutionari
methodolog
allow
interest
understand
virus
first
amplifi
sequenc
viral
nucleic
acid
name
dna
amplif
pcr
mulli
et
al
dna
sequenc
chaintermin
inhibitor
sanger
sequenc
firstgener
sequenc
sanger
et
al
use
technolog
even
fairli
basic
laboratori
could
amplifi
gener
base
sequenc
rel
easili
singl
day
appli
firstgener
sequenc
technolog
larg
scale
highli
special
sequenc
centr
first
larg
highprofil
genom
publish
notabl
homo
sapien
plasmodium
falciparum
mycobacterium
tuberculosi
cole
et
al
gardner
et
al
lander
et
al
main
limit
use
technolog
restrict
scalabl
cost
appli
larg
genom
frequent
relianc
prior
specif
templat
amplif
pcr
bacteri
clone
genom
project
larg
restrict
highprofil
organ
model
organ
human
pathogen
limit
mind
new
method
sequenc
develop
secondgener
commonli
nextgener
sequenc
ng
entir
revolution
abil
sequenc
overnight
possibl
gener
mani
million
base
sequenc
open
mani
new
opportun
make
largescal
sequenc
project
access
us
whatev
field
biolog
review
shall
give
overview
method
look
particularli
increas
applic
virolog
specif
viru
discoveri
genom
sequenc
transcriptom
dsdna
solut
first
shear
nebul
convert
fine
spray
amplifi
pcr
fragment
appropri
size
select
fig
fragment
bluntend
dephosphoryl
follow
ligat
two
separ
adapt
b
b
adapt
biotinyl
allow
subsequ
purif
use
streptavidinco
bead
subsequ
denatur
releas
bead
molecul
contain
primer
one
end
b
primer
molecul
constitut
dna
librari
bound
microbead
primer
hybrid
condit
favour
singl
molecul
per
bead
fig
subsequ
emuls
form
water
oil
mixtur
thu
captur
individu
bead
amplif
reagent
includ
primer
one
biotinyl
emuls
microreactor
fig
thermal
cycl
result
emulsionbas
clonal
amplif
individu
molecul
fig
amplif
emuls
disrupt
bead
coat
amplifi
product
enrich
use
streptavidinco
bead
magnet
separ
amplifi
product
denatur
bound
sequenc
primer
separ
individu
well
picotitr
plate
well
larg
enough
accommod
singl
bead
fig
sequenc
take
place
pyrosequenc
wherebi
nucleotid
incorpor
lead
releas
pyrophosph
ppi
fig
convert
via
atp
gener
light
amount
proport
number
base
incorpor
strength
system
read
length
approxim
base
make
particularli
suitabl
amplicon
sequenc
bridg
across
complex
sequenc
achil
heel
relianc
pyrosequenc
creat
difficulti
sequenc
homopolym
run
lead
error
rate
individu
read
mostli
attribut
insert
delet
gill
et
al
wang
et
al
whilst
depth
coverag
usual
overcom
becom
problemat
individu
read
data
use
assess
popul
divers
see
subsect
target
amplif
methodolog
start
similar
way
describ
dna
fragment
fig
ligat
bead
emuls
pcr
fig
follow
denatur
amplifi
product
bead
attach
glass
slide
sequenc
fig
densiti
bead
extrem
high
determin
ultim
number
read
achiev
unlik
methodolog
sequenc
occur
hybrid
ligat
fig
fluoresc
label
gener
sequenc
n
repres
degener
base
z
univers
modifi
base
bind
prefer
fig
specif
ligat
sequenc
come
dinucleotid
clearli
combin
sequenc
probe
label
one
four
dye
leav
individu
dye
associ
four
primer
sequenc
start
hybrid
primer
proce
progress
ligat
fluoresc
detect
identifi
sequenc
probe
pool
incorpor
cleavag
remov
label
three
univers
base
leav
place
newli
extend
strand
process
repeat
first
round
ligat
reaction
gather
sequenc
inform
posit
etc
process
repeat
start
primer
displac
nt
direct
upstream
allow
sequenc
inform
gather
posit
etc
process
repeat
start
primer
displac
nt
upstream
independ
ligat
reaction
start
five
primer
allow
softwar
recreat
final
sequenc
also
mean
posit
sequenc
interrog
twice
lead
high
accuraci
follow
dna
fragment
adapt
ligat
gel
purif
adapterlig
singlestrand
sequenc
anneal
glass
plate
precoat
oligo
complementari
adapt
fig
oligo
serv
captur
templat
dna
primer
subsequ
amplif
amplif
occur
slide
process
term
bridg
amplif
singlestrand
molecul
bind
end
oligo
primer
slide
success
round
pcr
result
gener
tini
island
cluster
amplifi
molecul
fig
serv
clone
subsequ
sequenc
use
chain
termin
similar
tradit
sanger
sequenc
howev
unlik
sanger
method
illumina
use
fluoresc
label
revers
termin
singl
base
incorpor
molecul
temporarili
termin
reaction
fig
highresolut
digit
imag
use
determin
nucleotid
incorpor
dna
clonal
cluster
imag
termin
revers
chemic
allow
templat
molecul
extend
next
round
sequenc
sequenc
reaction
proce
conclus
major
molecul
helico
first
true
singlemolecul
sequenc
technolog
enter
marketplac
templat
amplif
prior
sequenc
methodolog
start
similar
way
alreadi
describ
templat
fragment
adapt
ligat
fig
time
poli
adapt
ad
end
singlestrand
dna
templat
finish
singl
fluoresc
label
datp
poli
tag
use
captur
templat
molecul
onto
flow
cell
use
oligo
dt
probe
densiti
fig
laser
locat
bound
templat
prior
cleavag
fluoresc
label
dna
polymeras
fluoresc
label
revers
termin
nucleotid
ad
sequenti
imag
detect
incorpor
base
fig
method
use
sequenc
rna
directli
without
prior
cdna
synthesi
ozsolak
et
al
unlik
ng
technolog
method
dna
polymeras
immobil
floor
microcel
fragment
dsdna
ligat
hairpin
adapt
creat
circular
dna
fig
amplifi
linearli
use
primer
complementari
hairpin
sequenc
captur
singl
molecul
dna
polymeras
sequenc
bottom
well
zero
mode
waveguid
fig
fluoresc
label
nucleotid
one
colour
base
diffus
cell
unlik
system
fluoresc
molecul
phospholink
mean
cleav
incorpor
fig
label
nucleotid
diffus
around
polymeras
activ
site
gener
small
nois
signal
howev
dna
polymeras
encount
nucleotid
complementari
next
base
templat
incorpor
grow
dna
chain
held
place
order
magnitud
longer
averag
diffus
nucleotid
creat
measur
colour
signal
differenti
simpl
diffus
follow
incorpor
fluoresc
label
cleav
part
chemistri
form
phosphat
chain
diffus
away
allow
dna
polymeras
continu
incorpor
multipl
base
per
second
methodolog
first
stage
ion
torrent
sequenc
reli
ad
adapt
known
sequenc
templat
dsdna
ligat
pcr
adapt
use
captur
librari
clonal
onto
solid
particl
amplifi
target
sequenc
emuls
pcr
fig
amplifi
librari
separ
one
bead
per
well
highdens
array
fig
well
sit
top
ionsensit
semiconductor
dna
polymerasecatalys
extens
hydrogen
ion
releas
part
normal
chemistri
nucleotid
incorpor
fig
ion
detect
semiconductor
small
chang
ph
like
pyrosequenc
measur
releas
ppi
extent
chang
ph
ion
torrent
sequenc
determin
number
base
incorpor
render
sensit
misread
length
homopolym
decid
technolog
best
contenti
issu
ultim
depend
specif
experi
plan
import
factor
includ
size
genom
consid
complex
includ
gc
content
well
depth
coverag
accuraci
requir
therefor
import
take
advic
local
servic
provid
said
gener
principl
base
current
technolog
perform
may
help
guid
decisionmak
process
look
assembl
complex
genom
de
novo
longer
read
length
may
appropri
seek
faster
turnaround
time
smaller
platform
may
offer
greater
flexibl
depend
size
laboratori
loman
et
al
sequenc
roch
whilst
current
rel
expens
still
nich
amplicon
sequenc
longer
read
platform
may
appropri
direct
rna
sequenc
helico
long
read
pacbio
howev
singlemolecul
sequenc
accuraci
may
becom
import
issu
depend
experi
author
experi
illumina
solid
platform
current
offer
best
allround
valu
money
accuraci
throughput
rnaseq
see
subsect
transcriptom
project
requir
high
depth
coverag
amount
sequenc
gener
platform
may
seem
excess
viral
genom
typic
rang
size
kb
howev
case
sequenc
occur
solid
platform
whether
glass
microwel
plate
surfac
readili
partit
allow
sever
sampl
sequenc
independ
singl
run
machin
addit
use
distinct
adapt
contain
uniqu
sequenc
motif
tag
also
sequenc
reaction
librari
differ
sampl
mix
sequenc
togeth
sequenc
partit
back
respect
sampl
base
uniqu
sequenc
tag
adapt
process
usual
refer
barcod
addit
mani
compani
manufactur
platform
discuss
produc
smaller
machin
user
mind
one
crucial
featur
ultim
sequenc
success
templat
nucleic
acid
prepar
clearli
appropri
nucleic
acid
must
purifi
whether
rna
dna
oblig
intracellular
organ
viral
prepar
usual
heavili
contamin
host
nucleic
acid
wise
remov
much
practic
order
ensur
mani
result
sequenc
read
viral
rather
host
origin
dna
rna
virus
natur
contamin
nucleic
acid
may
vari
case
best
start
materi
contain
littl
genet
inform
cerebrospin
fluid
serum
howev
method
also
describ
cellular
materi
dali
et
al
mani
case
simpl
viral
purif
work
lowspe
centrifug
remov
cellular
debri
follow
highspe
sediment
concentr
packag
viral
genom
rnase
andor
dnase
treatment
use
remov
unpackag
unprotect
contamin
nucleic
acid
case
specif
purif
may
follow
base
densiti
gradient
goal
sequenc
one
small
number
genom
crude
purif
often
suffici
especi
academ
valu
genom
high
circumst
small
percentag
less
read
would
typic
viral
origin
goal
sequenc
mani
hundr
genom
import
achiev
full
genom
coverag
simpl
method
prior
viru
enrich
includ
pcr
need
recent
hybrid
captur
use
enrich
viral
nucleic
acid
prior
deep
sequenc
allow
whole
herpesviru
genom
sequenc
clinic
sampl
depledg
et
al
experi
clear
tradeoff
sampl
puriti
timecost
purif
project
need
assess
valu
informat
requir
ng
project
ignor
research
peril
arguabl
easi
gener
mani
million
base
sequenc
challeng
use
effici
full
discuss
informat
beyond
scope
articl
howev
key
process
pipelin
qualiti
score
sequenc
assembl
annot
manipul
typic
output
file
includ
individu
read
align
continu
sequenc
contig
challeng
due
size
postsequenc
two
approach
use
analysi
read
data
refer
genom
avail
sequenc
map
directli
refer
use
mapper
bwa
li
durbin
provid
rapid
inform
substitut
insert
delet
gene
loss
applic
aim
research
look
novel
gene
sequenc
circumst
suitabl
refer
genom
avail
individu
sequenc
read
assembl
de
novo
use
softwar
velvet
zerbino
birney
mira
chevreux
et
al
use
algorithm
find
overlap
inform
read
lead
gener
contig
approach
allow
discoveri
novel
gene
sequenc
well
small
variant
eg
snp
indel
de
novo
map
strategi
may
cover
entir
genom
due
either
insuffici
depth
coverag
genom
repeat
read
length
smaller
repeat
caus
gap
genom
assembl
size
gap
approxim
comparison
refer
genom
altern
may
cross
use
pairedend
matepair
librari
larger
fragment
dna
first
purifi
eg
kb
adapt
ad
either
end
molecul
circular
bring
two
region
genom
previous
separ
sever
thousand
base
close
contact
separ
adapt
circular
dna
molecul
fragment
sequenc
usual
way
allow
origin
end
molecul
sequenc
crucial
also
identifi
rel
posit
separ
genom
sequenc
pairedend
librari
built
informat
genom
scaffold
show
order
rel
posit
individu
contig
therebi
facilit
genom
closur
genom
gap
close
convent
pcr
follow
tradit
sanger
sequenc
whether
necessari
depend
natur
project
perhap
obviou
applic
technolog
genom
sequenc
although
viral
genom
rel
small
academ
valu
often
extrem
high
coupl
barcod
partit
ng
repres
highli
effici
way
sequenc
full
viral
genom
impract
provid
exhaust
list
viral
genom
publish
ng
list
would
rapidli
go
date
rather
provid
two
exampl
approach
chosen
extrem
viral
landscap
name
marseilleviru
dna
viru
one
largest
viral
genom
known
influenza
viru
small
segment
rna
viru
marseilleviru
belong
nucleocytoplasm
larg
dna
virus
ncldv
includ
poxvirus
asfarvirus
iridovirus
phycodnavirus
mimivirus
biggest
type
viru
genom
circular
dsdna
molecul
bp
boyer
et
al
despit
size
whole
genom
sequenc
achiev
singl
experi
f
ghislain
person
commun
total
orf
predict
encod
protein
rang
aa
code
sequenc
repres
genom
genom
repertoir
viru
compos
typic
ncldv
core
gene
well
gene
appar
obtain
eukaryot
host
parasit
symbiont
bacteri
viral
studi
led
author
propos
amoeba
melt
pot
microbi
evolut
divers
form
emerg
includ
giant
virus
complex
gene
repertoir
variou
origin
power
way
compar
famili
member
larg
genom
compar
ancestr
gene
set
ie
proport
genom
code
capac
conserv
member
famili
ncldv
gene
previous
identifi
compris
ancestr
gene
set
ncldv
eg
replic
machineri
rna
polymeras
subunit
transcript
factor
cap
polyadenyl
enzym
dnapackag
apparatu
structur
compon
icosahedr
capsid
viral
membran
identifi
marseilleviru
genom
suggest
whilst
marseilleviru
like
true
ncldv
relat
somewhat
distantli
known
viru
famili
almost
extrem
end
viral
biodivers
marseilleviru
influenza
virus
rel
small
segment
rna
genom
need
genom
sequenc
virus
driven
emerg
et
al
pandem
urgent
need
understand
evolut
molecular
epidemiolog
virus
ad
sequenc
complex
come
segment
genom
associ
recombin
event
mean
phylogenet
analys
base
partial
sequenc
inform
never
pick
full
complex
histor
recombin
event
often
lead
pandem
emerg
clearli
full
genom
sequenc
obtain
clinic
materi
segmentspecif
pcr
tradit
sanger
sequenc
smith
et
al
vijaykrishna
et
al
howev
recent
method
describ
base
pool
segmentspecif
pcr
obtain
directli
clinic
materi
et
al
follow
purif
viru
particl
cell
cultur
lorusso
et
al
follow
case
tag
sequenc
allow
mani
full
genom
sequenc
ng
effect
remov
major
bottleneck
understand
emerg
transmiss
import
virus
bailli
et
al
remain
challeng
reduc
time
sequenc
product
point
sequenc
inform
use
routin
real
time
aid
health
protect
agenc
control
outbreak
author
laboratori
use
ng
platform
obtain
de
novo
sequenc
multipl
viru
famili
includ
poxvirida
parvovirida
picornavirida
herpesvirida
asfarvirida
chapman
et
al
rhabdovirida
underli
broad
applic
techniqu
field
virolog
cleari
singl
full
genom
sequenc
incred
valuabl
understand
viru
biolog
perhap
interest
abil
ng
provid
sequenc
compar
multipl
full
genom
distinct
type
identifi
import
genet
differ
szpara
et
al
one
strike
featur
viral
genom
potenti
high
evolut
rate
featur
short
gener
time
rna
virus
particular
lowfidel
polymeras
mani
year
enshrin
concept
viral
quasispeci
wherebi
mani
rna
virus
believ
exist
sampl
level
singl
sequenc
collect
close
relat
variant
laur
andino
divers
creat
challeng
wish
sequenc
virus
mani
sequenc
rna
virus
particularli
base
pcr
without
clone
repres
averag
major
consensu
sequenc
popul
gener
minor
member
popul
ignor
case
entir
accept
practic
howev
evolutionari
term
exist
divers
repres
massiv
reserv
select
occur
fitter
variant
emerg
rapidli
concern
immun
escap
also
antivir
chemotherapi
minor
popul
variant
harbour
resist
mutat
rapidli
select
lead
failur
antivir
therapi
led
world
health
organ
establish
global
strategi
prevent
assess
human
immunodefici
viru
hiv
drug
resist
amongst
mani
role
global
influenza
surveil
respons
system
close
monitor
evolut
influenza
virus
infect
human
includ
suscept
antivir
drug
long
histori
attempt
character
viral
quasispeci
identifi
clinic
signific
minor
variant
within
gener
done
pcr
amplif
direct
sequenc
may
abl
detect
mutat
exist
frequenc
popul
varghes
et
al
wang
et
al
line
probe
assay
although
perhap
slightli
sensit
detect
known
mutat
lok
et
al
sensit
increas
use
limitingdilut
pcr
ie
essenti
sequenc
multipl
individu
molecul
sampl
howev
clearli
come
consider
cost
palmer
et
al
wang
et
al
comparison
gener
accept
ng
amplicon
detect
minor
variant
present
sequenc
read
varghes
et
al
accept
ng
detect
mani
minor
mutat
tradit
method
margeridonthermet
et
al
exampl
one
studi
hiv
popul
mutat
ultradeep
pyrosequenc
detect
averag
seven
time
variant
convent
method
variant
present
genom
variant
present
genom
confirm
limitingdilut
sequenc
wang
et
al
limit
detect
threshold
driven
error
rate
polymeras
use
pyrosequenc
error
around
homopolym
estim
amplifi
plasmid
sequenc
margeridonthermet
et
al
mitsuya
et
al
solmon
et
al
varghes
et
al
wang
et
al
author
knowledg
error
rate
associ
revers
transcript
includ
repres
import
area
futur
research
particularli
direct
rna
sequenc
becom
avail
ozsolak
et
al
ng
predominantli
use
monitor
popul
divers
hiv
eriksson
et
al
hoffmann
et
al
ji
et
al
wang
et
al
hepat
b
viru
hom
et
al
margeridonthermet
et
al
solmon
et
al
start
use
virus
geret
et
al
et
al
hiraga
et
al
tapparel
et
al
verbinnen
et
al
wellehan
et
al
methodolog
start
shed
new
light
area
viral
pathogenesi
minor
popul
variant
may
also
highli
signific
includ
assay
receptor
usag
raymond
et
al
minor
pathogen
variant
geret
et
al
studi
understand
immun
escap
simian
immunodefici
viru
bimber
et
al
hugh
et
al
studi
use
ng
dissect
dynam
transmiss
shed
new
light
differ
resist
acquir
transmiss
evolv
within
patient
varghes
et
al
addit
studi
move
away
sequenc
specif
genom
region
estim
divers
across
whole
genom
bimber
et
al
tapparel
et
al
willerth
et
al
approach
like
gener
new
insight
role
previous
understudi
viral
gene
pathogenesi
use
barcod
multiplex
provid
opportun
increas
costeffect
approach
hoffmann
et
al
ji
et
al
threat
newli
emerg
virus
import
speci
remain
everpres
human
although
virus
current
make
small
proport
known
human
diseas
make
major
newli
identifi
one
woolhous
gaunt
rate
discoveri
new
viru
infect
remain
larg
unchang
mani
decad
suggest
mani
new
virus
remain
discov
woolhous
et
al
face
new
outbreak
diseas
imper
rapidli
character
infecti
agent
understand
better
diseas
allow
develop
specif
diagnost
test
control
measur
ideal
method
nonspecif
includ
electron
microscopi
viru
isol
clone
degener
consensu
pcr
represent
differ
analysi
rda
sequenceindepend
singl
primer
amplif
sispa
ambros
clewley
bexfield
kellam
tang
chiu
highprofil
recent
exampl
sar
sever
acut
respiratori
syndrom
coronaviru
new
respiratori
syndrom
first
report
march
anonym
initi
largescal
screen
known
pathogen
carri
tri
identifi
common
factor
case
use
viru
isol
electron
microscopi
pcr
antigenbas
method
drosten
et
al
sever
red
her
identifi
notabl
paramyxoviru
ultim
random
pcr
drosten
et
al
degen
coronaviru
primer
ksiazek
et
al
amplifi
first
sar
coronaviru
sequenc
publish
electron
new
england
journal
medicin
april
juli
declar
sar
outbreak
contain
http
whilst
sar
stori
repres
consider
triumph
global
cooper
pathogen
discoveri
approxim
month
syndrom
descript
pathogen
discoveri
highli
like
futur
discoveri
project
would
carri
ng
fraction
time
describ
one
mani
exampl
show
speed
approach
outbreak
unexplain
haemorrhag
fever
peopl
report
south
africa
index
patient
admit
clinic
septemb
follow
week
secondari
tertiari
case
report
four
five
patient
die
outbreak
haemorrhag
fever
highli
emot
event
necessit
rapid
respons
control
infect
public
anxieti
rna
extract
two
postmortem
liver
biopsi
case
one
serum
sampl
case
submit
ng
blast
analysi
result
sequenc
identifi
contig
correspond
half
approxim
kb
genom
novel
arenaviru
bries
et
al
major
sequenc
obtain
serum
rather
tissu
presum
reflect
higher
level
host
dna
obtain
highli
cellular
tissu
sampl
rapid
result
highli
signific
sever
reason
method
use
predic
sequencespecif
amplif
high
probabl
success
provid
suffici
sequenc
done
inde
influenza
viru
shown
ng
sensit
clinic
specimen
close
specif
pcr
grening
et
al
secondli
rapid
pathogen
discoveri
access
outbreak
regardless
profil
diseas
report
recent
schmallenberg
viru
rumin
hoffmann
et
al
thirdli
work
quickli
allow
author
obtain
candid
diagnosi
h
final
use
novel
sampl
often
find
wealth
previous
unrecogn
virus
day
et
al
last
point
highlight
key
issu
clearli
identif
viral
sequenc
clinic
materi
far
show
associ
diseas
lipkin
case
small
studi
sought
compar
metagenom
health
diseas
includ
cystic
fibrosi
willner
et
al
chronic
fatigu
syndrom
sullivan
et
al
tri
determin
signific
one
genom
diseas
howev
cost
current
limit
approach
diseas
singl
pathogen
perhap
unlik
typic
tradit
method
employ
seek
proof
associ
newli
discov
viru
diseas
method
includ
classic
infect
studi
achiev
koch
postul
larger
studi
use
tradit
diagnost
method
pcr
compar
preval
new
viral
sequenc
health
diseas
detect
acquir
immun
show
tempor
associ
infect
diseas
even
done
like
ng
technolog
lead
identif
expand
class
virus
histor
would
call
orphan
virus
virus
search
diseas
commens
dolgin
latter
repres
excit
area
research
obviou
reason
much
virolog
histor
driven
virus
respons
diseas
technolog
ng
may
allow
us
open
window
role
virus
health
move
away
pathogen
discoveri
clinic
sampl
ng
use
increasingli
explor
viral
divers
wide
rang
environment
sampl
shed
new
light
might
consid
normal
recent
exampl
technolog
appli
includ
faec
donaldson
et
al
li
et
al
rey
et
al
sewag
cantalupo
et
al
vaccin
victoria
et
al
plant
notabl
grapevin
coetze
et
al
environment
sampl
includ
water
et
al
rodriguezbrito
et
al
recent
paper
describ
use
bloodfeed
mosquito
way
sampl
broad
rang
viral
divers
vectoren
metagenom
identifi
broad
rang
anim
plant
insect
bacteri
virus
ng
et
al
review
ocean
virom
suggest
sea
domin
rare
gene
mani
might
contain
within
viruslik
entiti
genetransf
agent
kristensen
et
al
studi
predict
wealth
dna
virus
belong
eukaryot
ncldv
suggest
rna
virom
domin
picornalik
virus
although
viru
candid
pathogen
discoveri
environment
viral
metagenom
broadli
thought
separ
disciplin
highli
relat
essenti
seek
identifi
correl
viru
popul
sampl
phenotyp
recur
theme
often
includ
use
sampl
low
contamin
host
nucleic
acid
faec
victoria
et
al
serum
towner
et
al
filtrat
sampl
remov
contamin
genet
materi
sequenceindepend
revers
transcript
pcr
amplif
capsidprotect
nucleaseresist
viral
nucleic
acid
wide
rang
undiscov
viral
divers
begin
illumin
import
challeng
identifi
truli
novel
sequenc
compar
newli
gener
sequenc
publish
databas
sever
approach
develop
facilit
includ
search
base
amino
acid
similar
recreat
theoret
ancestr
sequenc
delwart
molecular
method
sensit
ng
detect
rare
viral
transcript
frequenc
lower
moor
et
al
bring
consider
potenti
sampl
contamin
schmieder
edward
whilst
genom
data
clearli
extrem
valuabl
right
area
scienc
turn
increasingli
transcriptom
measur
mrna
achiev
new
insight
genom
express
may
modifi
health
diseas
histor
oligonucleotid
microarray
use
quantifi
gene
express
throughout
biolog
approach
larg
replac
ng
transcrib
rna
call
rnaseq
marioni
et
al
wilhelm
landri
key
step
process
firstli
includ
isol
rna
remov
host
genom
dna
subsequ
rrna
also
remov
select
polyadenyl
rna
remov
rrna
antisens
oligo
complementari
dna
synthesi
prime
either
oligo
dt
randomli
long
transcript
former
lead
bia
sequenc
end
failur
determin
transcript
start
site
strand
specif
transcript
lost
routin
prepar
doublestrand
cdna
howev
maintain
either
ad
differ
adapt
end
rna
transcript
mark
one
strand
degrad
chemic
modif
levin
et
al
analysi
rnaseq
data
usual
achiev
map
sequenc
read
refer
genom
use
softwar
map
read
gene
splice
junction
trapnel
et
al
statist
analysi
number
read
per
genom
region
gene
use
quantifi
rel
level
express
ander
huber
robinson
et
al
whilst
use
technolog
still
infanc
virolog
begin
provid
new
insight
genom
code
capac
biolog
transcript
particularli
larg
dna
virus
exampl
mimivirus
rnaseq
identifi
new
role
palindrom
sequenc
transcript
termin
byrn
et
al
confirm
predict
orf
transcrib
well
identifi
new
orf
legendr
et
al
poxvirus
rnaseq
use
revisit
tempor
trend
gene
express
yang
et
al
identifi
interact
host
poxvir
transcriptom
yang
et
al
map
transcript
start
stop
site
precis
yang
et
al
herpesvirus
new
insight
made
role
viral
gene
express
viru
latenc
lin
et
al
cytomegaloviru
signific
noncod
transcript
splice
variant
character
well
identifi
new
proteincod
transcript
gather
et
al
technolog
clearli
limit
larg
dna
virus
also
use
identifi
differ
express
posttranscript
modif
associ
lentiviru
virul
ertl
et
al
ng
also
provid
new
way
explor
role
microrna
viru
replic
pathogenesi
short
rna
molecul
base
length
function
neg
regul
mrna
translat
say
abdellatif
role
explor
sever
viral
system
includ
latenc
herp
simplex
viru
umbach
et
al
viru
riley
et
al
cytomegaloviru
stark
et
al
transform
marek
diseas
viru
burnsid
et
al
kaposi
sarcomaassoci
herpesviru
wu
et
al
grapevin
patholog
pantaleo
et
al
cours
two
side
transcriptom
virus
name
viru
host
virusinduc
perturb
host
transcriptom
clearli
critic
import
infect
outcom
howev
methodolog
limit
meant
recent
studi
pathogenesi
heavili
driven
target
analysi
specif
gene
pathway
thought
critic
diseas
progress
although
review
concentr
use
ng
studi
viral
sequenc
directli
clear
approach
provid
new
opportun
explor
interact
replic
virus
host
particularli
transcriptom
nontarget
hypothesisgener
mode
recent
exampl
includ
gene
profil
earli
advanc
liver
diseas
chronic
hepat
c
viru
hcv
infect
patient
khalid
et
al
replic
hcv
vitro
woodhous
et
al
host
gene
shutoff
kaposi
sarcomaassoci
herpesviru
identif
host
transcript
refractori
shutoff
clyde
glaunsing
despit
rapid
progress
made
technolog
last
year
new
develop
still
like
last
year
lot
public
around
singlemolecul
nanopor
technolog
aim
allow
simpl
cheap
singlemolecul
dna
sequenc
devic
larger
smartphon
eisenstein
technolog
work
pull
dna
tini
pore
read
base
pass
chang
electr
current
across
pore
process
could
remov
need
enzym
process
imag
complet
could
potenti
gener
long
read
rapidli
whilst
substanti
data
yet
seen
method
could
becom
avail
technolog
deliv
devic
could
avail
clinic
rapidli
afterward
becom
key
technolog
diagnost
medicin
avail
sequenc
chemistri
becom
establish
matur
read
length
fidel
increas
allow
us
explor
deeper
viral
genom
divers
major
platform
develop
easier
use
costeffect
major
compani
releas
cheaper
benchtop
machin
aim
democrat
technolog
make
readili
avail
loman
et
al
ultim
consequ
democrat
bring
ng
sequenc
mani
research
laboratori
well
routin
diagnost
human
anim
plant
diseas
therebi
provid
new
insight
complex
virom
live
medicin
routin
sequenc
human
genom
herald
new
opportun
person
medicin
perhap
follow
similar
opportun
allow
antivir
therapi
bettermatch
individu
genom
sequenc
exist
alreadi
happen
extent
hiv
improv
area
sampl
prepar
rapid
includ
recent
develop
genom
partit
also
known
enrich
allow
target
specif
region
set
gene
inde
entir
exom
technolog
platform
includ
either
microarray
solid
substrat
free
rna
dna
oligo
separ
fragment
use
biotin
tag
highthroughput
pcrbase
techniqu
review
mamanova
et
al
approach
may
particularli
appropri
virus
way
remov
contamin
host
dna
